Information  X 
Enter a valid email address

Company Name matching 'COMPASS Pathfinder Ltd.'

Date
Time Source
Company
Announcement
14 Sep 2021 12:00 pm GNW   COMPASS Pathfinder Ltd. COMPASS Pathways acquires IP portfolio of novel psychedelic compounds and prodrugs
10 Sep 2021 12:00 pm GNW   COMPASS Pathfinder Ltd. Hamilton Morris joins COMPASS Pathways to research new psychedelic compounds
11 Aug 2021 12:00 pm GNW   COMPASS Pathfinder Ltd. COMPASS Pathways plc announces financial results and business highlights for the second quarter 2021
29 Jul 2021 1:30 pm GNW   COMPASS Pathfinder Ltd. Guy Goodwin joins COMPASS Pathways as Chief Medical Officer
21 Jul 2021 12:00 pm GNW   COMPASS Pathfinder Ltd. Danielle Schlosser joins COMPASS Pathways from Verily Life Sciences to lead clinical innovation and therapist training
05 Jul 2021 11:00 am GNW   COMPASS Pathfinder Ltd. COMPASS Pathways joins forces with King’s College London and South London and Maudsley NHS Foundation Trust to accelerate psychedelic research and develop new models of mental health care in the UK
30 Jun 2021 12:00 pm GNW   COMPASS Pathfinder Ltd. COMPASS Pathways launches new podcast “Everyone has a story: talking about mental health”
28 Jun 2021 12:00 pm GNW   COMPASS Pathfinder Ltd. COMPASS Pathways completes COMP360 psilocybin therapy administration for 216 patients in large-scale phase IIb psilocybin therapy trial for treatment-resistant depression
23 Jun 2021 12:00 pm GNW   COMPASS Pathfinder Ltd. COMPASS Pathways becomes Founding Supporter of the British Neuroscience Association’s inaugural Scholars programme
03 Jun 2021 2:27 pm GNW   COMPASS Pathfinder Ltd. COMPASS Pathways and Kings College London publish cognition results from COMP360 psilocybin study in healthy volunteers
13 May 2021 12:00 pm GNW   COMPASS Pathfinder Ltd. COMPASS Pathways plc announces financial results and business highlights for the first quarter 2021
30 Apr 2021 1:45 am GNW   COMPASS Pathfinder Ltd. COMPASS Pathways announces pricing of public offering
27 Apr 2021 10:22 pm GNW   COMPASS Pathfinder Ltd. COMPASS Pathways launches proposed public offering
15 Apr 2021 8:00 am GNW   COMPASS Pathfinder Ltd. New England Journal of Medicine publishes exploratory study showing signals of positive activity in COMP360 psilocybin compared with escitalopram for major depressive disorder
09 Apr 2021 12:00 pm GNW   COMPASS Pathfinder Ltd. COMPASS Pathways plc to participate in 20th Annual Needham Virtual Healthcare Conference
01 Apr 2021 12:01 pm GNW   COMPASS Pathfinder Ltd. COMPASS Pathways appoints Wayne J Riley MD to its Board of Directors
23 Mar 2021 12:00 pm GNW   COMPASS Pathfinder Ltd. COMPASS Pathways granted two US patents
09 Mar 2021 12:00 pm GNW   COMPASS Pathfinder Ltd. COMPASS Pathways plc announces financial results and business highlights for fourth quarter and year-end 2020


Company Announcements Archive »


a d v e r t i s e m e n t